Hydroxyethylrutosides (also known as oxerutins, O-beta-hydroxyethyl-rutosides, HR, or HER) are semisynthetic derivatives of rutosides, which are naturally occurring flavonoid glycosides found in certain plants. While they are structurally related to the natural compound rutin, hydroxyethylrutosides are not present in food sources and are obtained only through pharmaceutical supplementation.
Chemical Composition and Types
Hydroxyethylrutosides are produced through hydroxyethylation of rutosides, resulting in several derivative compounds with varying levels of substitution. Common examples include:
- Monoxerutin
- Dihydroxyethylrutoside
- Troxerutin
- Tetrahydroxyethylrutoside
These compounds share a similar flavonoid backbone but differ in the number and position of hydroxyethyl groups, influencing their solubility and biological activity.
Medical Uses
Hydroxyethylrutosides are widely used in vascular medicine due to their ability to strengthen capillary walls and reduce microvascular leakage. Their therapeutic applications include:
- Chronic Venous Insufficiency (CVI): improving venous tone and reducing edema.
- Hypertensive Microangiopathy: enhancing microcirculatory function and reducing permeability of small blood vessels.
- Capillary Fragility: stabilizing endothelial function and minimizing leakage.
Commercial preparations such as Venoruton, Relvène, and Paroven contain mixtures of hydroxyethylrutosides. These products have been used as alternatives to horse chestnut (Aesculus hippocastanum) extracts, which contain the active compound aescin.
Typical therapeutic doses are approximately 1,000 mg per day, administered orally.
Mechanism of Action
Hydroxyethylrutosides exert their effects primarily through capillary protection and vascular modulation. They reduce capillary permeability, improve venous tone, and limit inflammatory responses in the endothelium. The compounds may also exhibit antioxidant properties, helping to neutralize free radicals that damage blood vessel linings.
Research and Pharmacology
Experimental studies have examined the protective effects of hydroxyethylrutosides in models of adriamycin-induced toxicity and other oxidative stress conditions. Findings suggest that these compounds may help mitigate tissue damage by preserving microvascular integrity and reducing oxidative stress markers.
Although clinical data support their efficacy in venous insufficiency, additional studies are needed to confirm their role in other circulatory and inflammatory disorders.
Safety and Tolerability
Hydroxyethylrutosides are generally well tolerated, with minimal reported side effects. Occasionally, patients may experience mild gastrointestinal discomfort or skin reactions. Unlike certain herbal venotonics, oxerutins have a low allergenic potential and are considered safe for long-term use under medical supervision.
Summary
Hydroxyethylrutosides represent a clinically validated group of flavonoid derivatives used primarily to improve venous circulation and capillary resistance. Through their antioxidant and vascular-protective actions, they remain a widely prescribed option for managing chronic venous disorders, microangiopathies, and related conditions.
